Eligibility criteria for Sacubitril-Valsartan in patients admitted for heart failure: the real world

被引:0
|
作者
David Cabrita Roque, D. [1 ]
Augusto, J. [1 ]
Santos, M. [1 ]
Candeias Faria, D. [1 ]
Baltazar Ferreira, J. [1 ]
Sacchetti, A. [2 ]
Melo, L. [2 ]
Oliveira Soares, A. [1 ]
Morais, C. [1 ]
机构
[1] Hosp Prof Fernando Fonseca EPE, Cardiol, Amadora, Portugal
[2] Hosp Prof Fernando Fonseca EPE, Internal Med, Amadora, Portugal
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1859
引用
收藏
页码:477 / 478
页数:2
相关论文
共 50 条
  • [31] Evaluating Patients With Heart Failure to Determine Eligibility for Sacubitril/Valsartan.
    Han, Jamie
    Nguyen, Quyen
    Chung, Francisco
    Mody, Freny
    Lie, J.
    Jackevicius, Cynthia
    CIRCULATION, 2018, 138
  • [32] Use of sacubitril/valsartan in patients with heart failure: evidence from the real world
    Valladales-Restrepo, Luis Fernando
    Sanchez-Ramirez, Nicolas
    Usma-Valencia, Andres Felipe
    Velasquez-Quirama, Santiago
    Henao-Martinez, Manuela
    Castro-Rodriguez, Jorge Alejandro
    Gaviria-Mendoza, Andres
    Machado-Duque, Manuel Enrique
    Machado-Alba, Jorge Enrique
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2211 - 2219
  • [33] Sacubitril/Valsartan in real world heart failure proctice in Asia
    Chu, P. H.
    Hsia, F. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 412 - 412
  • [34] Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting
    Nordberg Backelin, Charlotte
    Fu, Michael
    Ljungman, Charlotta
    ESC HEART FAILURE, 2020, 7 (03): : 1049 - 1055
  • [35] Safety and effectiveness of Sacubitril-Valsartan in a real-world population
    Mariana Tinoco, M.
    Cardoso, F.
    Dias, G.
    Pereira, T.
    Faria, B.
    Almeida, F.
    Leite, S.
    Lourenco, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 111 - 112
  • [36] Use and Out-of-Pocket Cost of Sacubitril-Valsartan in Patients With Heart Failure
    Shore, Supriya
    Basu, Tanima
    Kamdar, Neil
    Brady, Patrick
    Birati, Edo
    Hummel, Scott L.
    Chopra, Vineet
    Nallamothu, Brahmajee K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (17):
  • [37] TOLERABILITY OF SACUBITRIL-VALSARTAN IN PATIENTS WITH CANCER AND HEART FAILURE WITH REDUCED EJECTION FRACTION
    Yarrabothula, Akshitha R.
    Alsheikh-Kassim, Mohammad
    Amatullah, Atia
    Fossas, Jose
    Salman, Justin
    Seal, Zachary
    Lin, Heather
    Irizarry-Caro
    Wanna, Charles
    Miller, Chase
    Fatakdawala, Mariya
    Palaskas, Nicolas L.
    Deswal, Anita
    Koutroumpakis, Efstratios
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2325 - 2325
  • [38] Clinical benefit of sacubitril-valsartan in patients with heart failure with reduced ejection fraction
    Spinoni, Enrico Guido
    Lio, Veronica
    Degiovanni, Anna
    Erbetta, Riccardo
    Marino, Paolo
    Patti, Giuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N101 - N101
  • [39] REAL-WORLD USE OF SACUBITRIL-VALSARTAN IN THE SOUTH OF ENGLAND
    Dimarco, Anthony
    Haydock, Paul
    Flett, Andrew
    Cowburn, Peter
    Chandrasekaran, Badrinathan
    Foley, Paul
    Dixon, Giles
    Jackson, Thomas
    Critoph, Chris
    Davis, Hannah
    Kelly, Dominic
    HEART, 2020, 106 : A72 - A73
  • [40] Real-world use of sacubitril-valsartan in the South of England
    Dimarco, A. Anthony D.
    Haydock, P. H.
    Flett, A. S.
    Cowburn, P. J.
    Chandrasekaran, B.
    Foley, P.
    Dixon, G.
    Davis, H.
    Critoph, C.
    Jackson, T.
    Kelly, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 233 - 234